Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Development of a pulmonary peptide delivery system using porous nanoparticle-aggregate particles for systemic application.

Yang L, Luo J, Shi S, Zhang Q, Sun X, Zhang Z, Gong T.

Int J Pharm. 2013 Jul 15;451(1-2):104-11. doi: 10.1016/j.ijpharm.2013.04.077. Epub 2013 May 4.

PMID:
23651645
2.

Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.

Cheow WS, Ng ML, Kho K, Hadinoto K.

Int J Pharm. 2011 Feb 14;404(1-2):289-300. doi: 10.1016/j.ijpharm.2010.11.021. Epub 2010 Nov 18.

PMID:
21093560
3.

Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery.

Bi R, Shao W, Wang Q, Zhang N.

J Biomed Nanotechnol. 2009 Feb;5(1):84-92.

PMID:
20055110
4.

Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.

Ungaro F, d'Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, La Rotonda MI.

J Control Release. 2009 Apr 2;135(1):25-34. doi: 10.1016/j.jconrel.2008.12.011. Epub 2008 Dec 25.

PMID:
19154761
5.

Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model.

Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, Bedirli A, Ozlu O, Pasaoglu H.

Anesth Analg. 2008 Mar;106(3):830-7, table of contents. doi: 10.1213/ane.0b013e3181616fc9.

PMID:
18292427
6.

Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles.

Kawakami K, Sumitani C, Yoshihashi Y, Yonemochi E, Terada K.

Int J Pharm. 2010 May 10;390(2):250-9. doi: 10.1016/j.ijpharm.2010.02.018. Epub 2010 Feb 17.

PMID:
20170721
7.

Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.

Wu X, Hayes D Jr, Zwischenberger JB, Kuhn RJ, Mansour HM.

Drug Des Devel Ther. 2013;7:59-72. doi: 10.2147/DDDT.S40166. Epub 2013 Feb 4.

8.

Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung.

Wanakule P, Liu GW, Fleury AT, Roy K.

J Control Release. 2012 Sep 10;162(2):429-37. doi: 10.1016/j.jconrel.2012.07.026. Epub 2012 Jul 27.

PMID:
22841795
9.

Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.

Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F.

J Control Release. 2012 Jan 10;157(1):149-59. doi: 10.1016/j.jconrel.2011.08.010. Epub 2011 Aug 16.

PMID:
21864595
10.

Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.

Sonaje K, Lin KJ, Wey SP, Lin CK, Yeh TH, Nguyen HN, Hsu CW, Yen TC, Juang JH, Sung HW.

Biomaterials. 2010 Sep;31(26):6849-58. doi: 10.1016/j.biomaterials.2010.05.042. Epub 2010 Jun 17.

PMID:
20619787
11.

Insulin-micro- and nanoparticles for pulmonary delivery.

Klingler C, Müller BW, Steckel H.

Int J Pharm. 2009 Jul 30;377(1-2):173-9. doi: 10.1016/j.ijpharm.2009.05.008. Epub 2009 May 14.

PMID:
19446621
12.

Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.

Nolan LM, Tajber L, McDonald BF, Barham AS, Corrigan OI, Healy AM.

Eur J Pharm Sci. 2009 Jul 12;37(5):593-602. doi: 10.1016/j.ejps.2009.05.007. Epub 2009 May 20.

PMID:
19463948
13.

Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation.

Hou A, Li L, Huang Y, Singh V, Zhu C, Pan X, Quan G, Wu C.

Drug Deliv Transl Res. 2018 Mar 29. doi: 10.1007/s13346-018-0515-7. [Epub ahead of print]

PMID:
29600480
14.

Formulation strategy and use of excipients in pulmonary drug delivery.

Pilcer G, Amighi K.

Int J Pharm. 2010 Jun 15;392(1-2):1-19. doi: 10.1016/j.ijpharm.2010.03.017. Epub 2010 Mar 17. Review.

PMID:
20223286
15.

Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin.

Dorkoosh FA, Coos Verhoef J, Ambagts MH, Rafiee-Tehrani M, Borchard G, Junginger HE.

Eur J Pharm Sci. 2002 Jun;15(5):433-9.

PMID:
12036720
16.

A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.

Wang Y, Kho K, Cheow WS, Hadinoto K.

Int J Pharm. 2012 Mar 15;424(1-2):98-106. doi: 10.1016/j.ijpharm.2011.12.045. Epub 2011 Dec 31.

PMID:
22226876
17.

Nanoparticles for drug delivery to the lungs.

Sung JC, Pulliam BL, Edwards DA.

Trends Biotechnol. 2007 Dec;25(12):563-70. Epub 2007 Nov 8. Review.

PMID:
17997181
18.

Preparation of nanoparticles by spray-drying and their use for efficient pulmonary drug delivery.

Li HY, Zhang F.

Methods Mol Biol. 2012;906:295-301. doi: 10.1007/978-1-61779-953-2_23.

PMID:
22791442
19.

The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.

Zhang Y, Zhu J, Tang Y, Chen X, Yang Y.

Drug Dev Ind Pharm. 2009 Sep;35(9):1059-65. doi: 10.1080/03639040902769628.

PMID:
19640250
20.

Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117.

Qian F, Mathias N, Moench P, Chi C, Desikan S, Hussain M, Smith RL.

Int J Pharm. 2009 Jan 21;366(1-2):218-20. doi: 10.1016/j.ijpharm.2008.10.020. Epub 2008 Nov 5.

PMID:
19027057

Supplemental Content

Support Center